A study published in a journal of the American Association for Cancer Research shows that lung cancer patients those taking statins before or after diagnoses of lung cancer can reduce the risk of death due to lung cancer. Statins are those drugs which are taken to reduce the cholesterol level and all of us know that cholesterol is a kind of fat in our body which is not good for us.
Northern Ireland researchers also discovered that those who were taking statins before diagnosing lung cancer can reduce the death by 19%. But, the study of Chris Cardwell a senior lecturer in medical statistics at the Centre for Public Health at Queen’s University Belfast in Northern Ireland shows that the risk of less death among lung cancer patients who have taking statins before or after diagnoses of lung cancer is relatively small. He also said that their study provide some evidences of lung cancer patients who used statins during or before their diagnoses had a reduction in risk of death.
Some British study also said that patients who newly diagnoses with lung cancer and are prolonged to use of statins, especially simvastatin, can reduce the death by 19%. Among on all of the lung cancer patients who are prolonged to use of statins, reduction in risk of death is 12%.
For his study Cardwell and his colleagues collected a data of 14,000 newly diagnoses lung cancer patients between 1998 and 2009 from English cancer registry data, also from the U.K. Clinical Practice Research Datalink they collected patient’s prescription records and from the Office of National Statistics they collected mortality data up to 2012.
In this study results there is no difference between small cell lung cancer patients and non-small cell lung cancer patients, noted by Cardwell.
Dr. Cardwell also included that there are many number of differences between patients who take statins and patients who don’t that may be indicated the reduction in risk of death among lung cancer. So, we do not totally say that only the prolonged use of statins before or after diagnoses of lung cancer is a single factor of reduction in risk of lung cancer death among patients who take statins and patients who don’t.